347740 — P&K Skin Research Center Co Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeSmall CapHigh Flyer

Annual income statement for P&K Skin Research Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12,499	14,676	17,487	17,957	14,843
Cost of Revenue
Gross Profit	9,150	10,331	11,298	11,113	7,199
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	6,823	7,460	11,025	12,317	13,463
Operating Profit	5,676	7,217	6,462	5,640	1,379
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,316	7,782	8,526	8,190	5,357
Provision for Income Taxes
Net Income After Taxes	5,376	6,719	7,293	7,130	4,700
Minority Interest
Net Income Before Extraordinary Items
Net Income	5,376	6,719	7,293	7,130	4,813
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,376	6,719	7,293	7,130	4,813
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	220	260	246	239	160
Dividends per Share